Effectiveness of Respiratory Muscle Training with a Mobile Application After Lobectomy
Launched by HACETTEPE UNIVERSITY · Feb 3, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective a mobile application can be in helping patients strengthen their breathing muscles after a lobectomy, which is a type of surgery to remove part of the lung often due to lung cancer. Researchers have noticed that after this surgery, patients may experience weakness in their respiratory muscles, which can make it harder to breathe. The trial aims to see if starting breathing exercises early after surgery can help patients recover better and stay motivated by providing visual feedback through the app.
To participate in this trial, you need to be a lung cancer patient who is scheduled for a lobectomy and is between 18 and 65 years old. You should also be in stable health and willing to take part in the study. However, if you have certain conditions that affect your ability to walk or have had previous surgeries that could impact your chest area, you may not be eligible. If you join the study, you can expect to use the mobile app to perform breathing exercises designed to help improve your lung strength during your recovery. The trial is not yet recruiting participants, so it’s a good idea to keep an eye out for updates if you’re interested.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteering to participate in the study,
- • Being clinically stable,
- • Being a lung cancer patient with a planned lobectomy with VATS,
- • Being between the ages of 18-65,
- • Being able to cooperate with the tests to be performed.
- Exclusion criteria:
- • Having any orthopedic or neurological problem that prevents walking,
- • Having undergone any surgery related to the thoracic wall,
- • Having diseases that will affect respiratory parameters such as severe heart failure, severe chronic obstructive pulmonary disease (COPD).
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Ebru Calik Kutukcu, Professorr
Study Director
Hacettepe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported